X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Orchid Chemicals Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Quarterly Results   (ORCHID)

Here are the latest quarterly results of Orchid Chemicals. For more details, see the Orchid Chemicals financial fact sheet and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Orchid Chemicals Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-15
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
8-Qtr Chart
Click to enlarge
Net Sales Rs m3,0482,5632,1082,0382,0841,9091,8771,800 
Other income Rs m1000920062 
Turnover Rs m3,0482,5632,1082,0382,1761,9091,8771,862 
Expenses Rs m3,1882,0891,8071,7881,7401,7921,6231,547 
Gross profit Rs m-140475301250345117254253 
Depreciation Rs m603368357358351345347352 
Interest Rs m1,045710757761713692712694 
Profit before tax Rs m-1,787-603-814-870-628-920-805-732 
Tax Rs m-789-128-1257010-120-120-122 
Profit after tax Rs m-999-476-689-940-637-800-685-610 
Gross profit margin %-4.618.514.312.216.56.113.514.0 
Effective tax rate %44.121.115.3-8.0-1.513.014.916.7 
Net profit margin %-32.8-18.6-32.7-46.1-30.6-41.9-36.5-33.9 
Diluted EPS Rs -11.7 -5.6 -8.1 -11.0 -7.5 -9.4 -8.0 -7.2  
Diluted EPS (TTM) Rs -34.0 -28.8 -33.3 -36.4 -32.2 -36.0 -35.9 -32.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   MERCK LTD  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDOCO REMEDIES  

Compare ORCHID PHARMA LTD With:   MERCK LTD  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  INDOCO REMEDIES  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes the Day in Red on Weak Corporate Earnings(Closing)

Indian share markets finished the trading week below the dotted line as the August derivatives series began on a subdued note amid disappointing earnings by corporates.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

Trade the Markets like Roger Federer Plays Tennis(Daily Profit Hunter)

Jul 19, 2017

Trading is one of the most competitive fields in the world today. To win, you must adopt the mindset of a Grand Slam champion.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

Why Keeping Unrealistic Expectations From Investments Is Stupid!(Outside View)

Jul 18, 2017

When investing, keeping realistic returns is necessary and it is not the only thing you should look at.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 28, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - STERLING BIOTECH COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS